Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
C. E. Hoeve, B. D. Gier, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Short-and Mid-term Cardiac Outcomes in Multisystem Inflammatory Syndrome in Children
S. Pinninti, C. Hebson, et al.
Characterizing and Predicting Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) in a Large Academic Medical Center in the US
L. G. Fritsche, W. Jin, et al.
Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
T. Arashiro, Y. Arima, et al.
Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
P. T. V. Florentino, F. J. O. Alves, et al.
